Caribou Biosciences, Inc.

US$0.45As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CRBUHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (49.35%)
Div yield —
ROE (93.80%)
Biotechnology
Beta (5Y) 2.49
PE TTM —
TSR TTM (81.46%)
Mkt cap US$48.10M
ROIC (48.76%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.454
1.08%
(11.06%)
Buy 11|12|5|5|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
25.69%
9.78%
(1.65%)
(0.18%)
Revenue$M
2.162
2.102
2.119
2.104
(1.65%)
(3.12%)
(1.87%)
(3.26%)
Peers (US$48.10M)
Cap (US$)
PE
47.50M
—
Capital
TTM
5Y
10Y
Leveragex
0.115
0.086
0.083
EBIT/Intx
4.630
0.365
0.292
Own earn%
(1495.37)
(146.43)
(148.06)
Sh yield%
39.16
51.61
52.30
Owners
Insiders/Inst%
1.00
35.98
Short interest%
0.71
SBC / revenue%
0.51
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
27–32
$1 testx
−0.1
Incr. ROIC%
22